Drugs / Botulin toxin
Trials 1
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 2 | NCT01747161 | Dec 2013 → Nov 2014 | vulvodynia | University Hospital, Ghent | Completed | No outcome recorded |
Evidence & citations 5 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | Botulin toxin | ClinicalTrials.gov intervention name — accepted as the source's own label NCT01747161 ↗ |
| Known as | Botox | “Botulin toxin (Botox) is a neurotoxin that causes a temporary paralysis of the muscle cells.” NCT01747161 ↗ |
| Action | Inhibit | “Botox also inhibits the pain receptors in the vestibulum.” NCT01747161 ↗ |
| Modality | Other / unclassified | “Botulin toxin (Botox) is a neurotoxin that causes a temporary paralysis of the muscle cells.” NCT01747161 ↗ |
| Route | Other | “Injections in 6 spots of the vestibulum vaginae” NCT01747161 ↗ |